TRIOCHEM PRODUCTS LTD. Share Price

₹ 0.00

-₹17.40 (--%)

Last updated 01 Jan, 1970, 17:30 IST

BSE: 512101

Pharmaceuticals

100.00% down today

1D LOW

1D HIGH

TRIOCHEM PRODUCTS LTD. Stock Insights

TRIOCHEM PRODUCTS LTD. stock performance
Open	--
High	--
Low	--
Prev. close	₹17.40

TRIOCHEM PRODUCTS LTD. trading activity
Volume	--
Average traded price	--
Last traded time	05:30:00 01 Jan
Last traded quantity	--

₹16.53₹18.27

Circuit Low

Circuit High

----

52-Week Low

52-Week High

Circuit

₹16.53

₹18.27

52-week

Mkt Cap Cr

0.43

P/E

0.05

P/B

0.02

ROA

38.79%

ROE

-3.14%

ROCE

-2.76%

Quick Ratio

417.71

EV/EBITDA

0.0

Mkt Cap Cr

0.43

P/E

0.05

P/B

0.02

ROA

38.79%

ROE

-3.14%

ROCE

-2.76%

Quick Ratio

417.71

EV/EBITDA

0.0

Based on fundamentals, this stock's

Valuation

Overvalued

Triochem Product appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,24,202.42	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,74,402.47	83.09	9.49	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,26,811.28	95.17	20.92	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,195.62	45.15	5.81	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.45	4.07	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

TRIOCHEM PRODUCTS LTD. Company Background

ISIN

INE331E01013

Sector Market Cap

₹ 0.43 Cr

Triochem Products Limited is an India-based company, which is engaged primarily in the business of manufacturing and exporting pharmaceuticals products, active pharmaceutical ingredients (APIs) and chemicals. The Company operates through a single segment, which is chemical and pharmaceutical. The Company is an exporter of pharmaceutical bulk drugs and organic and inorganic chemicals. Its product range includes iodine compounds, citrates and piperazine salts. Its main markets include Europe (Germany, France, Netherlands, United Kingdom), America (United States, Brazil, Mexico, Guatemala) and Southeast Asia (Korea, Indonesia, Taiwan, Australia).

TRIOCHEM PRODUCTS LTD. Financial Highlights

Revenue: TRIOCHEM PRODUCTS LTD. reported revenue of ₹0.86 crore in FY26 vs ₹1.05 crore in FY25. It showed a decrease of 18.10% on a yearly basis.
Operating Profit: TRIOCHEM PRODUCTS LTD. reported an operating profit of ₹10.52 crore in FY26 vs ₹0.25 crore in FY25. It showed an increase of 4,308.00% on a year-on-year basis.
Net Profit: TRIOCHEM PRODUCTS LTD. reported a net profit of ₹7.97 crore in FY26 vs ₹0.40 crore in FY25. It showed an increase of 2,092.50% on a yearly basis.

TRIOCHEM PRODUCTS LTD. Quarterly Result Highlights

TRIOCHEM PRODUCTS LTD. reported revenue of ₹0.17 crore in Jun 2026, compared with ₹0.13 crore in Mar 2026, representing an increase of 30.77% on a quarter-on-quarter (QoQ) basis.
TRIOCHEM PRODUCTS LTD. reported an operating profit of ₹0.12 crore in Jun 2026, compared with ₹10.99 crore in Mar 2026, representing a decrease of 98.91% on a quarter-on-quarter (QoQ) basis.
TRIOCHEM PRODUCTS LTD. reported a profit of ₹0.09 crore in Jun 2026, compared with ₹8.33 crore in Mar 2026, reflecting a decrease of 98.92% on a QoQ basis.
The earnings per share (EPS) of TRIOCHEM PRODUCTS LTD. stood at ₹325.34 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

68.65%

FII

0.00%

Other DII

0.00%

Retail and other

31.35%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%
Sep 2026	0.00%

TRIOCHEM PRODUCTS LTD. Investment Returns

1 day

1 week

1 month

1 year

3 years

5 years

TRIOCHEM PRODUCTS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹0.00	₹0.00	₹0.00	₹0.00
Other Income	₹0.86	₹1.05	₹1.03	₹0.28
Total Revenue	₹0.86	₹1.05	₹1.03	₹0.28
Total Expenses	₹1.51	₹1.30	₹1.20	₹1.45
Profit Before Tax	₹10.52	-₹0.25	-₹1.33	-₹1.17
Tax	₹2.55	₹0.15	-₹0.32	-₹0.28
Profit After Tax	₹7.97	-₹0.40	-₹1.01	-₹0.89
EPS - Basic	₹325.34	-₹16.33	-₹41.36	-₹36.12
EPS - Diluted	₹325.34	-₹16.33	-₹41.36	-₹36.12

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹10.52	-₹0.25	-₹1.33	-₹1.17
Income before WC changes	-₹0.98	-₹0.56	-₹1.72	-₹1.33
Change in Assets	₹0.30	₹0.74	-₹1.96	-₹0.09
Change in Liabilities	-₹0.21	₹0.04	-₹0.01	₹0.03
Change in WC	₹0.09	₹0.77	-₹1.97	-₹0.06
Cash flow from Operations	-₹2.87	₹0.20	-₹3.76	-₹1.03
Cash flow from Investing	₹13.70	₹0.17	₹3.34	-₹9.82
Cash flow from Financing	₹0.00	₹0.00	₹0.00	₹0.00
Total Cash Flow	₹10.82	₹0.37	-₹0.42	-₹10.85
Cash (Start of the year)	₹0.91	₹0.54	₹0.96	₹11.81
Cash (End of the year)	₹11.73	₹0.91	₹0.54	₹0.96

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹7.89	₹11.37	₹12.16	₹10.55
Current Assets	₹12.99	₹2.52	₹2.73	₹1.28
Total Assets	₹20.88	₹13.89	₹14.89	₹11.84
Current Liabilities	₹0.03	₹0.22	₹0.27	₹0.24
Net Current Asset	₹12.96	₹2.30	₹2.46	₹1.04
Non-Current Liabilities	₹0.20	₹0.00	₹0.00	₹0.00
Equity Capital	₹20.65	₹13.67	₹14.62	₹11.60
Total Equity & Liabilities	₹20.88	₹13.89	₹14.89	₹11.84